Portside Wealth Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
PFM
Portside Wealth Group's LMAT Position: Q3 2026 in Review
Portside Wealth Group reduced its LeMaitre Vascular (LMAT) stake by 0.53% in Q3 2026, selling an estimated $3.01K and leaving 6,356 shares worth $525K. The position accounts for 0.06% of the portfolio, ranked #302.
Portside Wealth Group first reported a position in LMAT in Q3 2024 and has held it in 9 quarters since. The position peaked at $688K in Q1 2026. 28 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Portside Wealth Group held 6,356 shares of LeMaitre Vascular worth $525K as of Q3 2026.
- Portside Wealth Group sold 34 LeMaitre Vascular shares in Q3 2026, an estimated $3.01K.
- LeMaitre Vascular made up 0.06% of Portside Wealth Group's portfolio in Q3 2026, its #302 holding.
- Portside Wealth Group first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 9 quarters since.
- Portside Wealth Group's LeMaitre Vascular position peaked at $688K in Q1 2026.
- 28 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.